PharmAthene, Inc. (PIP) Reports First Quarter 2013 Financial and Operational Results
5/8/2013 2:22:50 PM
More...
|
PharmAthene, Inc. (PIP) to Host First Quarter 2013 Conference Call And Webcast on Wednesday, May 8, 2013
5/7/2013 12:01:42 PM
More...
|
New Data Show PharmAthene, Inc. (PIP)'s Recombinant Bioscavenger Binds to a Broad Spectrum of Chemical Nerve Agents
4/17/2013 9:52:46 AM
More...
|
PharmAthene, Inc. (PIP) to Host Year-End 2012 Conference Call and Webcast on Wednesday, March 13, 2013
3/13/2013 9:14:10 AM
More...
|
PharmAthene, Inc. (PIP) to Present at the Noble Financial 9th Annual Equity Conference on Tuesday, January 22, 2013
1/17/2013 7:50:32 AM
More...
|
PharmAthene, Inc. (PIP) Secures Exclusive License to PER.C6® Cell Line for Commercial Production of Recombinant Bioscavenger
1/14/2013 10:24:05 AM
More...
|
PharmAthene, Inc. (PIP) Announces Delaware Supreme Court Hears Oral Arguments in Its Litigation With SIGA Technologies, Inc. (SIGA)
1/10/2013 1:07:13 PM
More...
|
PharmAthene, Inc. (PIP) Reports Third Quarter 2012 Financial Results
11/7/2012 9:46:19 AM
More...
|
PharmAthene, Inc. (PIP) to Host Third Quarter 2012 Conference Call and Webcast on Tuesday, November 6, 2012
11/6/2012 9:10:19 AM
More...
|
PharmAthene, Inc. (PIP) Release: Department of Defense Exercises Options Under Contract for Nerve Agent Medical Countermeasure Program
8/10/2012 10:35:42 AM
More...
|
|